COVID-19 pandemic
India's Serum Institute announces that it will halve the production of its COVID-19 vaccine because it has no new orders for the vaccine.
Sources: BBC News
Changes
- India's Serum Institute will halve the production of its COVID-19 vaccine because it has no fresh orders, its top-ranking executive has said.
- India's Serum Institute will halve the production of its COVID-19 vaccine because it has no fresh orders, says its top-ranking executive.
- India's Serum Institute announces that it will halve the production of its COVID-19 vaccine because it has no new orders for the vaccine.